VHM — Full Portfolio
3 tracked investments · listed companies and verified rows first
HealthtechSan Jose, US
Mir Hashim(Executive Officer, Director)
BoardMir Imran(Executive Officer, Director)
Board seatAndrew Farquharson· per SEC Form D · $52.3M raise · filed Jun 2015
Co-investorsInCube Ventures
HealthtechEmeryville, US
Daniel Burnett(Director)Ulric Cote(Executive Officer, Director)Carter Meyer(Director)Bill Malecki(Executive Officer)
BoardDr. Jason Hong(Director)Anthony Natale(Director)in
Board seatAndrew Farquharson· per SEC Form D · $29.5M raise · filed Jul 2015
Co-investorsAPERTURE Venture PartnersGreen Park & Golf VenturesScientific Health DevelopmentThird Point VenturesLongwood Fund
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.
BiotechDeep TechMedical DevicesBerkeley, US
Brian Thomas(Executive Officer, Director, Promoter)in
BoardJak Knowles(Director)
Board seatAndrew Farquharson· per SEC Form D · $27.3M raise · filed Aug 2019
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalHumboldtInCube Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.